Showing 1–12 of 29 results

AVONEX 30 µg/0,5 ml Luer Lock Inj.Lsg.i.e.Fert.-S.(interferon beta-1a), 4

2,274.47
Outpatient treatment of patients with multiple sclerosis (to reduce the frequency and severity of exacerbations and slow the progression of disability).

AVONEX 30 µg/0,5 ml Luer Lock Inj.Lsg.i.e.Fert.-S.(interferon beta-1a),12

7,255.92
Outpatient treatment of patients with multiple sclerosis (to reduce the frequency and severity of exacerbations and slow the progression of disability).

AVONEX 30 µg/0,5 ml Luer Lock Inj.Lsg.i.e.Fert.-S.(interferon beta-1a),4

2,481.39
Outpatient treatment of patients with multiple sclerosis (to reduce the frequency and severity of exacerbations and slow the progression of disability).

AZZALURE 10 Speyw.E./0,05 ml Plv.z.Her.e.Inj.-Lsg. (Clostridium botulinum), 1 (Kohlpharma GmbH)

185.72
This concentration is used in most international clinical studies of the effectiveness of correction of glabellar wrinkles.

Betaserc (Betahistine) 8mg, 30

0.00
Pharmacological action - histamine-like.

CellCept (Mycophenolate mofetil) 250mg, 100

199.50
Pharmacological action - immunosuppressive.